Clinical Trials Search at Vanderbilt-Ingram Cancer Center

A Window of Opportunity Study of Low-Dose Neoadjuvant Nivolumab in Head and Neck Squamous Cell Carcinoma (HNSCC)

Disease Sites:

Head/Neck

Staging:

Phase I

Age Group:

Adults

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Rosenthal, Eben

Scope:

Local

Participating Institutions:

Vanderbilt University

Open Date:

05-13-2026

Trial Type:

Diagnostic

Protocol ID:

VICCHN25078

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available